Published

Opening Doors of Perception: Psychedelic Drugs and End-of-Life Care

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: JNCI Journal of the National Cancer Institute
Date: 2012-10-25
Source: OpenAlex
DOI: 10.1093/jnci/djs468
PubMed: 23104218

Authors

Norra MacReady

Watch author

Derived topics and classifications

psilocybin Depression Anxiety End-of-Life Distress Chronic Pain Consciousness Aging Spirituality Mystical Experience Review Article Healthy Volunteers Adolescents Cancer Patients Healthcare Workers Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Opening Doors of Perception: Psychedelic Drugs and End-of-Life Care2012-10-25

Related papers

The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-08-01 Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-06-22 Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-08-07 Psilocybin and human longevitynpj Aging · 2026-04-03 Psilocybin-Assisted Therapy for Prolonged GriefClinicalTrials.gov · 2026-06-23 The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive DisorderClinicalTrials.gov · 2026-07-17 Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-samplingClinicalTrials.gov · 2026-06-05 Psilocybin treatment extends cellular lifespan and improves survival of aged mice.npj aging · 2025-07-08